Isoginkgetin stabilizes atherosclerotic plaques by targeting NR4A2 to modulate the PPAR signaling pathway and reprogram ceramide metabolism, thereby inhibiting vascular smooth muscle cell phenotypic transformation

International Immunopharmacology 2026

View at publisher
Authors: Dongsheng Wei, Zhen Zhong, Han Li, Jiajie Qi, Yuting Liu, Huimin Cao, Yixin Ma, Zheng Li, Guanlin Yang, Youming Jiang, Zhe Zhang
DOI: 10.1016/j.intimp.2026.116993
Cited by: 1
References: 66

Fields of Study & Subjects

Nuclear Receptors and Signaling Peroxisome Proliferator-Activated Receptors Cholesterol and Lipid Metabolism

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
185
Pages
116993–116993
Publication date
10 June 2026
Language
EN